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Our work on mouse models of Loeys-Dietz syndrome (LDS) has shown that 
these mice recapitulate human disease and develop aortic root aneurysm, which is 
associated with a signature of increased transforming growth factor  (TGFβ) signaling. 
As in Marfan syndrome (MFS), aortic disease in LDS mouse models is sensitive to and 
fully reversed by the action of losartan, an angiotensin receptor blocker (ARB) that 
blunts TGF signaling, highlighting the molecular overlap between these two diseases. 
The instrumental role that mouse models of both MFS and LDS have played in 
furthering our knowledge of the pathophysiology of these diseases illustrates the 
importance of animal models for the study of human genetic disorders. However, the 
realization that the genetic background of an animal model can modulate the clinical 
expression of disease-specific phenotypic features has also highlighted the need for 
understanding the role of natural genetic variation in phenotypic variability. 
The research presented in this dissertation is based on the observation that in the 
context of LDS, there is great phenotypic variability associated with specific mouse 
strain backgrounds. We went on to prove that while postnatal aneurysm progression, 
which is associated with excessive TGFβ signaling, is blunted upon crossing LDS 
mutations onto a C57BL/6J (B6) background, LDS mice on this background also show 
high penetrance of perinatal death due to persistent truncus arteriosus with interrupted 
aortic arch (PTA/IAA), a congenital heart defect previously associated with insufficient 
TGFβ signaling in the cardiac neural crest.  
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To assess the effect of the B6 background on the phenotype we performed a test 
of dominance. A single cross of Tgfbr2
G357W/+
 mice congenic on a 129S6/SvEvTac 
(129SvE) background to B6 resulted in 67% of mutant pups with PTA/IAA, while the 
control backcross onto 129SvE only resulted in 3.7% (n=1/27) of mutant pups with 
PTA/IAA (p<1E-9, Fisher's exact test). In the context of this mutation, we concluded 
that the B6 background has a major dominant effect with incomplete penetrance on the 
generation of PTA/IAA, which could be due to other loci that act in a recessive or 
dosage-dependent manner. Interestingly, a test of dominance performed with 
Tgfbr1
M318R/+
mice yielded complete absence of outflow tract defects, leading to the 
conclusion that in this scenario, the B6 background had a recessive effect on the 
generation of PTA/IAA, which was confirmed when a second backcross onto this 
background was performed and 50% of the mutant pups showed PTA/IAA. 
Since PTA is introduced when LDS mutations are bred onto a mixed 
background, we used this discrete phenotype to map the relevant modifier alleles. 
Tgfbr2
G357W/+ 
mice on a pure 129SvE background were bred to F2 WT mice with 
extensive recombination between B6 and 129SvE chromosomes. The resulting E17.5 
fetuses were phenotyped for TA/IAA and DNA from the phenotyped embryos was 
collected and genotyped using a SNP array specially designed for mouse intercrosses 
and linkage studies. 
A genome-wide analysis revealed a single major B6-specific locus associated 
with TA/IAA on mouse chromosome 9, with a -log10(p)=9 at a map position coincident 




Tgfbr2 emerged as a promising candidate modifier gene on chromosome 9, both 
by virtue of its known function and the presence of strain-specific variation in the 
3'UTR. We recognized that variation in the 3'UTR can affect regulation of gene 
expression and went on to test for potential strain-specific Tgfbr2 expression 
differences. In addition, an unbiased search for microRNAs (miRNAs or miRs) that 
target Tgfbr2 revealed that miR-20b and miR-106a were potential candidates because 
they are encoded within the suggestive association peak on chromosome X. A luciferase 
reporter allele harboring the B6 Tgfbr2 3'UTR showed dramatically reduced expression 
when compared to its 129SvE counterpart (p<1E-9). Moreover, luciferase activity was 
equalized between the reporter alleles with strain-specific 3’UTRs upon addition of a 
miR-106a or miR-20b antagonist. Taken together, these data suggest that strain-specific 
differences in Tgfbr2 expression are fully accounted for by variable susceptibility to 
miR-mediated suppression of translation.  
To further understand if these changes in gene regulation affect the levels of 
TβRII protein on the surface of cells in the arterial wall and, subsequently, TGF 
activity, we isolated vascular smooth muscle cells (VSMCs) from WT B6 and 129SvE 
animals and stimulated them with low concentrations of TGFβ1 ligand. Surface levels 
of TRII and intracellular levels of phosphorylated SMAD2 (pSMAD2; the major 
readout of TGFβ pathway activity) were measured by flow cytometry. Higher levels of 
TRII and intracellular pSMAD2 were observed VSMCs isolated from 129SvE mice. 
While the severity of postnatal phenotypes driven by excessive TGFβ signaling, 
such as aneurysm progression, is significantly ameliorated on a B6 background when 
compared to 129SvE in the context of a LDS mutation, the development of prenatal 
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phenotypes associated with insufficient TGFβ levels is greatly accentuated. We provide 
evidence for a complex architecture of background-specific phenotypic modification in 
LDS and perhaps other TGFβ vasculopathies. We show that Tgfbr2 gene expression is 
influenced by the levels of microRNAs, such as miR-106a and miR-20b, as well as by 
the differences in accessibility of these miRs to the 3'UTR of Tgfbr2 mRNA, which are 
dictated by sequence variants that distinguish B6 from 129SvE in this gene region. 
In summary, we present evidence that suggests a novel regulatory mechanism of 
TGFβ signaling in the context of LDS-causing mutations. This mechanism is associated 
with overt defects in heart morphogenesis (increased risk of PTA/IAA) and postnatal 
aortic wall homeostasis (suppression of postnatal aortic aneurysm progression). 
It is our strong conviction that therapeutic strategies that mimic nature’s success 
at attenuating postnatal vascular disease on the B6 background (prominently including 
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1. CHAPTER 1. INTRODUCTION 
 
1.1 TGFβ signaling 
Transforming growth factor-beta (TGFβ) is a potent cytokine that belongs to a 
family of dimeric polypeptide growth factors that also includes bone morphogenic 
proteins (BMPs) and activins. TGF can modulate a variety of cellular functions and 
physiologic processes including cell proliferation, differentiation, apoptosis and synthetic 
repertoire and regulation of embryonic development, wound healing, and angiogenesis 
(Blobe et al., 2000). The TGFβ family is highly conserved throughout the entire 
metazoan subkingdom. 
There are three different TGF isoforms: TGFβ1, TGFβ2 and TGFβ3. Each is 
encoded by a different gene that is expressed in a tissue-specific and developmentally-
regulated pattern. TGF activity can have different consequences depending on context. 
For example TGF can induce differentiation of stem cells but cell cycle arrest in 
epithelial cells. The number of genes under control of the TGFβ pathway varies from a 
few in pluripotent stem cells to hundreds in differentiated cells (Massague, 2012). 
TGFβ signals trough a tetrameric receptor complex comprised of two type I and 
two type II receptor subunits. The ligand binds exclusively to the type I receptor subunit 
(ALK5 or TβRI) which is known as the signal propagating receptor; the ALK5-ligand 
complex then binds the type II receptor subunit (TRII), also known as the activating 
receptor. In the classical or canonical TGFβ-dependent signaling cascade, gene 
expression is regulated by receptor-mediated activation of SMAD transcription factors, 
including SMAD2 and SMAD3 (receptor-activated SMADS or R-SMADS), which are 
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phosphorylated by the Ser/Thr kinase domain in the type II receptors. Phosphorylation of 
SMAD2 and SMAD3 leads to association with SMAD4 (co-SMAD) and subsequent 
translocation of this complex into the nucleus, where it regulates expression of many 
target genes in association with other DNA-binding transcription factors (See Figure 1-1). 
Extensive cross-talk exists between this pathway and other signaling pathways. 
For example, activation of the mitogen-activated kinase (MAPK) pathways by other 
growth factors can lead to inhibitory phosphorylation of SMAD2 and SMAD3 in the 
regulatory “linker region”, and thus inhibition of signaling propagation (Massague, 
2012). Ligand-activated TGF receptors can also activate the MAPKs ERK, JNK and 
p38 (examples of so-called non canonical TGF signaling). 
 
1.2 Perturbation of TGFβ signaling in Loeys-Dietz Syndrome and other TGFβ 
vasculopathies 
Loeys-Dietz Syndrome (LDS) is a recently described aortic aneurysm syndrome 
with autosomal dominant inheritance and systemic manifestations that include aggressive 
aneurysms throughout the arterial tree, arterial tortuosity, hypertelorism, bifid uvula and 
cleft palate. Other common manifestations include clubfoot deformity, craniosynostosis 
and congenital heart defects in the form of bicuspid aortic valve (BAV), atrial septal 
defect (ASD) and patent ductus arteriosus (PDA) (Loeys et al., 2005). LDS shows 
significant phenotypic overlap with another connective tissue disorder called Marfan 
syndrome (MFS), which is caused by heterozygous mutations in the gene encoding the 
extracellular matrix protein fibrillin-1 (FBN1) (Dietz et al., 1991). 
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LDS is caused in the majority of cases by heterozygous mutations in the genes 
encoding either the type I (TGFBR1) or type II (TGFBR2) TGF receptor subunits. Less 
commonly, LDS is caused by heterozygous mutations in the genes encoding SMAD3 (an 
intracellular mediator of signaling) or the TGF2 ligand. LDS belongs to a class of 
connective tissue disorders (CTDs) that are caused by mutations in genes that code for 
different effectors or regulators of the TGFβ signaling pathway, unified by a tissue 
signature for high TGF signaling, referred to as the TGFβ vasculopathies. This list 
includes Marfan Syndrome (MFS), Shprintzen-Goldberg Syndrome (SGS), Arterial 
Tortuosity Syndrome (ATS), Bicuspid Aortic Valve with Aneurysm (BAAV), some 
forms of Ehlers-Danlos Syndrome (EDS) and Recessive Cutis Laxa.  See Table 1 for a 
list of the genes altered in these diseases. 
The role of TGFβ in the development and progression of aortic aneurysm has 
been under intense scrutiny. Studies done with tissue samples from patients with MFS, 
LDS and other disorders that present with aortic aneurysm show a consistent signature 
for high TGFβ signaling, as evidenced by increased phosphorylation of SMAD proteins 
(SMAD2 and SMAD3) as well as increased phosphorylation and activation of signaling 
molecules belonging to the so called non-canonical TGFβ pathway (ERK1/2, JNK and 
p38)(Habashi et al., 2011; Holm et al., 2011; Neptune et al., 2003). Intriguingly, LDS-
causing mutations almost always substitute conserved amino acids in the serine/threonine 
kinase domain of either TGFβ receptor subunit, and render the mutant receptors unable to 
propagate signaling when expressed in cells naïve for the corresponding subunit 
(Mizuguchi et al., 2004). More recently, heterozygous loss-of-function mutations in 
SMAD3 or TGFB2 have also been associated with syndromic presentations of thoracic 
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aortic aneurysm and have been designated as new subtypes of LDS, LDS3 and LDS4, 
respectively (Lindsay et al., 2012; van de Laar et al., 2011). The fact that loss-of-function 
mutations in positive regulators of TGFβ signaling lead to syndromes associated with a 
tissue signature of excessive and not, as one might expect, defective signaling has led to 
great controversy in the field regarding the precise role of TGFβ signaling in aneurysm 
development and the wisdom of therapeutic strategies aimed at TGF antagonism. 
Analysis of tissue samples obtained from patients or mouse models has clearly shown 
that high TGFβ signaling correlates with the development and progression of aortic 
aneurysms and many of the features of MFS, LDS and other TGFβ vasculopathies. 
However, other phenotypic features of LDS, most prominently cleft palate, have a clear 
association with impaired TGFβ signaling (Bush and Jiang, 2012; Proetzel et al., 1995).  
The cause of these paradoxical findings has not been fully elucidated, but it is likely that 
it will rest in the complexity of the interactions between different cell types in each 
particular context. 
 
1.3 Perturbation of TGFβ signaling and Congenital Heart Defects 
Embryonic development of the heart is a process in which cell lineages of diverse 
origins contribute to the different structures of this organ. While most of these structures 
are derived from the mesoderm, others, like the cushions that will form the outflow tract 
(OFT) and the pharyngeal arches, are also composed by ectoderm-derived cardiac neural 
crest cells (CNCCs) and by cells from the second heart field (SHF) (Mjaatvedt et al., 
2001). Formation of the heart tube and its subsequent looping to form a four-chambered 
structure involves the fine regulation of several signaling cascades that will regulate 
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proliferation, migration and differentiation of many cell types in highly specific patterns. 
CNCCs populate the pharyngeal arch arteries early in heart development (between day 
E8 and E10 of mouse embryonic development) where they will form the 
aorticopulmonary septum, which is the structure that will divide the OFT into the aorta 
and the pulmonary artery (Jiang et al., 2000). This process involves a very well-
orchestrated process of proliferation and migration of the different cell types involved, 
and is therefore highly sensitive to changes in the molecules that regulate these processes, 
prominently including those in the TGFβ and the BMP pathways (Marvin et al., 2001; 
Schneider and Mercola, 2001). 
In mice, homozygous deletion of Tgfb1 or Tgfb2 causes perinatal lethality due to a 
vast array of heart malformations. Cell specific manipulations of TGFβ signaling in 
CNCCs by homozygous deletion of either Tgfbr1 or Tgfbr2 in this lineage results in 
deficient septation of the outflow tract, which manifests in the form of patent truncus 
arteriosus and/or interrupted aortic arch (PTA or IAA, respectively) (Choudhary et al., 
2006). Zhou et al showed that SHF-specific deletion of the gene encoding latent TGFβ- 
binding protein 3 (Ltbp3) in zebrafish affects the elongation of the cardiac tube and 
formation of the precursors of the OFT (Zhou et al., 2011). Deletion of genes encoding 
other factors in the TGFβ pathway, such as the latent TGFβ-binding protein 1L (Ltbp1l), 
also cause PTA and IAA in mice (Todorovic et al., 2007).  
 
1.4 Modifiers of Disease 
Geneticists have long been fascinated by the fact that even “simple” Mendelian 
traits are influenced by genetic variation at loci distinct from the primary disease locus, a 
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phenomenon referred to as genetic modification (Bridges, 1919). Often a particular 
Mendelian disorder is caused by a variety of different mutations in the same gene, called 
allelic heterogeneity, which can dictate a striking range of phenotypic diversity (Romeo 
and McKusick, 1994). Adding to this complexity, variation in environmental exposures 
can also profoundly influence phenotypic expression (environmental modification). Thus, 
it can be difficult to attribute with certainty the source of clinical modification in human 
populations that show a diversity of underlying primary disease alleles, variation at other 
genetic loci and environments. As we will discuss below, the use of animal models of 
disease can provide powerful tools to dissect this complexity.  
 
1.5 Animal models in the study of genetic diseases 
The use of animal models to study the inheritance of phenotypic traits has been 
documented back to the early 1900’s. Gregor Mendel started his studies of inheritance by 
breeding mice with different coat colors, and only moved on to study pea plants after his 
Bishop threatened to close the monastery where he resided (Paigen, 2003). By the 1930’s 
an extensive framework had been developed in mice to interrogate important biological 
processes that ranged from cancer to immunology. Institutions like the Roscoe B. Jackson 
Memorial Laboratory (currently known as The Jackson Laboratory) were formed 
specifically to push forward the development of animal models to address all these topics 
(Paigen, 2003). Mice became the ultimate model organism to study biochemical 
pathways and mammalian physiology with the advent of genetic maps, first crudely 
defined by restriction fragment length polymorphisms (RFLPs) but later refined using 
millions of single nucleotide polymorphisms (SNPs) that distinguish different inbred 
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mouse strains. The Mouse Genomes Project has made publicly available sequencing data 
from 17 inbred mouse strains and a comprehensive catalogue of structural and sequence 
variants across these strains has been built from these data (Yalcin et al., 2012). 
The notion that a certain mutation, whether artificially introduced in mice or 
naturally occurring, could exhibit strong phenotypic variation when bred onto mice from 
different strains became rapidly evident. One of the earliest examples is the modulation 
of severity of intestinal obstruction-related death in various strains of mice with a 
mutation in the Cftr gene (mutations in this gene cause cystic fibrosis in humans) 
(Rozmahe et al., 1996). Another example was the description of the modification of the 
phenotype of Apc mutant mice (colon cancer model) that are intercrossed to mixed 
backgrounds (Dietrich et al., 1993). 
These early findings promoted further analysis of the variation of traits across 
different strains of mice. Ultimately, this lead to massive efforts to provide researchers 
with tools that could be used to refine mechanistic understanding of such phenotypes.  
Among these, the early description of genetic linkage maps of the mouse (Copeland et 
al., 1993) and the characterization of the genealogy of the different mouse strains (Beck 
et al., 2000) provided a strong foundation. More recent initiatives include the 
Collaborative Cross (Churchill et al., 2004) and the development of high-density 
genotyping arrays specifically designed to detect intercross-specific differences 




1.6 Figures: Chapter 1  
1.6.1 Figure 1-1. The TGFβ pathway 
 
Figure 1-1. TGFβ signaling pathway. The TGFβ receptor is a heterotetramer 
comprised by TβRI and TβRII (encoded by the genes Tgfbr1 and Tgfbr2, respectively). 
Activation by TGFβ ligands initiates signaling through the SMAD pathway (canonical 




1.7 Tables: Chapter 1 
1.7.1 Table 1-1. Catalogue of Connective tissue disorders referred to as “TGFβ 
vasculopathies” 





Mode of inheritance 
Loeys-Dietz Syndrome type I TGFBR1 609192 AD 
Loeys-Dietz Syndrome type II TGFBR2 610168 AD 
Loeys-Dietz Syndrome type III SMAD3 613795 AD 
Loeys-Dietz Syndrome type IV TGFB2 614816 AD 
Marfan Syndrome FBN1 154700 AD 
Shprintzen-Goldberg Syndrome 
Ehlers-Danlos Syndrome type IV 
Arterial Tortuosity Syndrome 
Cutis Laxa with Aneurysm 




















2. CHAPTER 2. CHARACTERIZATION OF THE POSTNATAL EFFECT OF 
C57BL/6J/129S6/SvEvTac MIXED BACKGROUND ON THE 
DEVELOPMENT OF AORTIC ANEURYSMS IN LDS MICE 
2.1 Introduction 
Evidence for the influence of genetic background on the expression of different 
traits has been documented extensively in several species. In the case of the laboratory 
mouse (Mus musculus domesticus), the effect of different genetic backgrounds on the 
expression of phenotype in the presence of the same underlying genetic variant has been 
known for more than 40 years (Coleman and Hummel, 1973; Crawley et al., 1997). 
Institutions like The Jackson Laboratories and others have devoted great efforts to 
understanding the genomic architectures of the strains of mice more commonly used in 
biomedical research and this has resulted in a comprehensive catalogue of the different 
strains of mice in terms of their potential uses for different studies. Ultimately, initiatives 
to characterize the genetic variation across the most commonly used strains of mice have 
generated databases where comparisons between strains at the sequence level can be done 
using a web-based interface (Keane et al., 2011; Yalcin et al., 2012; Yalcin et al., 2012), 
facilitating the identification of new genotype-phenotype correlations. 
More specifically, modification of cardiovascular phenotypes across different 
strains of mice has been well documented. In 2009, Wheeler et al. used intercrosses 
between DBA/2J and C57BL/6J to map a discrete region on mouse chromosome 3 that 
explained the vast majority of phenotypic variation in a murine model of dilated 
cardiomyopathy (Wheeler et al., 2009). In regard to modification of TGFβ-related 
phenotypes, it has been shown that a murine model of MFS displays great variation in the 
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progression of the aortic root dilatation and subsequent aneurysms when comparing 
129SvE and C57BL/6J mice (Lima et al., 2010). We therefore tested the hypothesis that 
other TGFβ vasculopathies, and more specifically LDS, would display the same 
phenotypic variation and if so, could be used to further define genetic modifiers of the 
TGFβ pathway. For this purpose, we used mouse models of LDS that carry point 





) and that display all the phenotypic features of the 







We tested the effect of a single backcross onto C57BL/6J on the progression of 
aortic disease in LDS mouse models carrying the Tgfbr1
M318R
 allele and congenic in a 
129S6/SvEvTac background (Gallo et al., 2014). While there was no significant 
difference between 129S6/SvEvTac congenic and mixed background Tgfbr1
M318R/+
mice 
at 8 or 16 weeks of age, by 24 weeks, 129S6/SvEvTac congenic Tgfbr1
M318R/+
 mice 
showed more severe enlargement of the aortic root as compared to mutant mice in a 
mixed background (p<0.007) (Figure 2-1). An ANOVA test yielded statistical 
significance for the interaction between backcross status and genotype (p<1E-8), and 
backcross status, genotype status and age (p<1E-4). 
We then analyzed the aortic root growth rate in these mice. This was calculated 
by subtracting the aortic root size at 8 weeks of age from the aortic root size at 24 weeks 
of age. Our results show that LDS mice that are in a mixed background show an aortic 
root growth rate that is significantly lower than that observed with a congenic 
129S6/SvEvTac background (p<0.0005) and almost identical to that for wild-type 






Enlargement of the aortic root and aortic tear (dissection) are cardinal features of 
the TGFβ vasculopathies, including MFS and LDS. Murine models for these diseases 
(previously generated in our lab) have provided significant insights into the pathogenesis 
of these diseases and have consistently shown a signature of high TGFβ signaling in 
aortic tissue (Gallo et al., 2014; Lindsay and Dietz, 2011; Neptune et al., 2003). Our 
results indicate that the C57BL/6J background has a protective effect on the aortic root 
phenotype of LDS mouse models. 
While a protective effect for the C57BL/6J background had been previously 
proposed in mouse models of MFS through indirect methods to measure the severity of 
the aortic phenotype (Lima et al., 2010), our results thoroughly document the progression 
of aortic aneurysms in our murine models of LDS in each strain. Our data shows that 
different strain backgrounds significantly modify the phenotype of a monogenic disease 
caused by mutations in a critical component of the TGFβ pathway. Differences in aortic 
root growth rate become significant by 24 weeks of age and have the strong potential to 
prevent the catastrophic outcome of LDS (i.e. death due to aortic dissection). . 
In subsequent chapters, we will describe the identification of the strain-specific 





2.4 Materials and methods 
2.4.1 Animal models 
Animals were housed and experiments were performed with approval by the 





 LDS mice were previously generated and described (Gallo et al., 2014).  
Six- to twelve-week old wild-type C57BL/6J (Strain# 000664, The Jackson Laboratory 





 males congenic on a 129S6/SvEvTac 
background. The resulting litters were genotyped for the presence of the respective LDS 
mutations, as described elsewhere (Gallo et al., 2014). 
 
2.4.2 Acquisition of echocardiographic measurements 
Echocardiograms were obtained using a parasternal long-axis view and 3 
independent measurements of the maximal internal dimension at the sinus of Valsalva on 
conscious mice whose hair was removed with Nair cream, using the Visualsonics Vevo 
660 V1.3.6 imaging system (VisualSonics). Imaging and measurements were performed 
by a cardiologist who was blinded to genotype and strain background. 
 
2.4.3 Statistical analysis 
Statistical analyses were done with the package R (http://www.R-project.org). 





 percentiles, respectively; internal line defines the median, and 
the whiskers define the range. Open circles denote outliers (as defined by the statistical 
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algorithm), but all values are used in the generation of plots and significance values.  In 
pairwise comparisons, p-values refer to unpaired 2-tailed Student’s t test. Standard two-





2.5 Figures: Chapter 2 
2.5.1 Figure 2-1. C57BL/6J background has a protective effect on the progression of 
postnatal aortic disease in a murine model of LDS 
 
Figure 2-2. Aortic root size was measured at the Sinuses of Valsalva as described 






2.5.2 Figure 2-2. Aortic root growth Rate of LDS mice congenic on a 129S6/SvEvTac 
background is significantly higher than LDS mice in a mixed background 
 
 
Figure 2-2. Aortic root growth rate was measured as the difference in the aortic 
root size of an animal at 24 weeks minus the aortic root size at 8 weeks of age (first 






2.6.1 Table 2-1. Sample sizes for echocardiographic measurements of Tgfbr1M318R/+ 
and wild-type littermates in different strains backgrounds 
Genotype Strain Age (in weeks) # 
Tgbr1
+/+ 
Congenic 129SvE 8 27 
Tgfbr1
M318R/+
 Congenic 129SvE 8 7 
Tgbr1
+/+ 
C57Bl/6J/129SvE F1 8 11 
Tgfbr1
M318R/+
 C57Bl/6J/129SvE F1 8 20 
Tgbr1
+/+ 
Congenic 129SvE 16 27 
Tgfbr1
M318R/+
 Congenic 129SvE 16 7 
Tgbr1
+/+ 
C57Bl/6J/129SvE F1 16 12 
Tgfbr1
M318R/+
 C57Bl/6J/129SvE F1 16 17 
Tgbr1
+/+ 
Congenic 129SvE 24 24 
Tgfbr1
M318R/+
 Congenic 129SvE 24 6 
Tgbr1
+/+ 
C57Bl/6J/129SvE F1 24 12 
Tgfbr1
M318R/+
 C57Bl/6J/129SvE F1 24 17 
Tgbr1
+/+ 
Congenic 129SvE 32 18 
Tgfbr1
M318R/+
 Congenic 129SvE 32 5 
Tgbr1
+/+ 
C57Bl/6J/129SvE F1 32 5 
Tgfbr1
M318R/+





3. CHAPTER 3. CHARACTERIZATION OF A C57BL/6J-SPECIFIC 




      Modulation of phenotype due to differences in genetic background across 
inbred mouse strains has been extensively studied (Churchill, 2007; Nadeau, 2001).  
While some authors have directed their efforts to studying the modulation of 
developmental phenotypes (i.e. CHDs), others have noted that phenotypes expressed in 
the postnatal stage are also subject to great variation among different strains of mice. Due 
to the inbred nature of the different strains of mice, these efforts are almost invariably 
focused on finding regions of the genome that distinguish the strains involved in these 
studies and trying to correlate this variation to the phenotype of interest. This approach 
had relative success in the late 1990’s with several studies pinpointing “regions of 
interest” associated with phenotypes that ranged from specific CHDs to more generalized 
phenotypes such as perinatal lethality. 
Among this group, several authors have linked defects in vascular development 
and perinatal lethality with regions in the mouse genome that modify the function of the 
TGFβ pathway along with an inherent perturbation in the model (i.e mice null for a 
component of the TGFβ pathway) leading to the understanding that elements in the 
mouse genome that vary between different strains negatively affect TGFβ signaling status 
(Bonyadi et al., 1997; Tang et al., 2003). While the results from these studies indicate that 
for each phenotype studied there will be one or more regions in the genome that 
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segregate accordingly, it is not clear whether these regions can be interrogated in the 
search for a molecular mechanism that directly links the phenotypic variation with any 
particular effector of the TGFβ pathway. 
As mentioned in chapter 2, during our studies on the phenotypic characteristics of 
our murine models of LDS, we generated mutant mice that were both congenic on a 
129S6/SvEvTac background as well as mice that harbored a mixed background between 
this strain and C57BL/6J. While one backcross onto C57BL/6J had no effect on the 
expected Mendelian ratio of mutant to wild-type littermates in the progeny of 
Tgfbr1
M318R/+
 mice, one single backcross to C57BL/6J was sufficient to cause 67% 
perinatal lethality with Tgfbr2
G357W/+
 mice due to the presence of septation defects in the 
OFT such as PTA or IAA. These defects were observed by sacrificing pregnant females 
at E17.5 days of gestation, in order to allow completion of the OFT septation process 
(which takes place between E9.5 and 13.5 days of gestation) and avoid perinatal lethality 
as a confounding factor in our estimations of the penetrance of OFT defects. 
The relationship between OFT defects and TGFβ signaling has been highlighted 
in chapter 1. Here, we show that in the Tgfbr2
G357W/+
 LDS mouse model, the presence of 
OFT defects strictly correlates with the C57BL/6J genomic contribution; we go on to 
show that penetrance of this trait is high when the Tgfbr2
G357W
 mutation is expressed on a 
mixed background generated by the first backcross of 129SvEvTac onto C57BL/6J (N1), 
which suggests the presence of at least one modifier locus with a dominant (or 




3.2.1 Patent Truncus Arteriosus (PTA) is a pseudodominant trait in mouse models of 
Loeys-Dietz Syndrome 
The effect of a single backcross (N1) onto C57BL/6J from 129S6/SvEvTac 





) was addressed by performing a test of dominance for 
the presence of OFT defects (PTA and/or IAA). 
0% of E17.5 pups carrying the Tgfbr1
M318R/+
genotype presented with OFT 
defects. However, analysis of Tgfbr2
G357W/+
 E17.5 embryos revealed that 67% of them 
were affected by OFT defects, mainly in the form of PTA (Figure 3-1). This documented 
dominant inheritance with incomplete penetrance in the context of the 
Tgfbr2
G357W/+
genotype. Results are summarized in table 3-1. 
When Tgfbr1
M318R/+
male mice resulting from the test of dominance (50% 
C57BL/6J; 50% 129SvE) were further crossed to wild-type C57BL/6J females, 
approximately 50% of the mutant E17.5 embryos showed OFT defects (table 3-2), an 







The data generated from our test of dominance supports our prior observation that 
documented the impossibility of backcrossing any of the LDS-causing mutations 
previously mentioned onto a C57BL/6J background past the second or third backcross. 
While the results of the test of dominance performed with Tgfbr2
G357W/+
embryos strongly 
support the hypothesis of a single major dominant effect (as concluded from a penetrance 
of ≈ 70%), the results observed with Tgfbr1
M318R/+
 embryos delineate a recessive nature 
of modification for the presence of OFT defects. The observation that mutations in the 
different subunits of the TGFβ receptor interact in differing ways with the C57BL/6J 
haploid set of chromosomes suggests a complex mechanism of regulation. We 
hypothesize that PTA requires a reduction of TGF signaling below a critical threshold 
(summarized in figure 3-2). This is achieved with a LDS mutation in one allele of a 
TGF receptor gene (Tgfbr2) and a hypomorphic opposing (C57BL/6J) allele of the same 
gene (figure 3-2A) or a LDS mutation in one allele of a TGF receptor gene (Tgfbr1) and 
two hypomorphic (C57BL/6J) alleles of the other TGF receptor gene (Tgfbr2) (figure 3-
2C).  
In chapter 6, we will investigate in greater detail the genetic variation between the 
two strains of interest, with the ultimate goal of revealing potentially novel regulatory 
mechanisms of the TGFβ signaling pathway which might modulate both pre- and post-




3.4 Materials and methods 
3.4.1 Generation of E17.5 LDS embryos with mixed genetic background 
Animals were housed and experiments were performed with approval by the 





 LDS mice were previously generated and described by our lab (Gallo et al., 
2014).  Six- to twelve-week old wild-type C57BL/6J (Strain# 000664, The Jackson 
Laboratory (Jax), Bar Harbor, ME) or 129S6/SvEvTac female mice (Taconic 




 males congenic on a 
129S6/SvEvTac background. Following timed-mating and halothane-induced euthanasia 
of pregnant females, E17.5 embryos were harvested and their cardiovascular anatomy 
was observed upon dissection of the abdominal and thoracic walls and injection with 
approximately 0.5 ml of yellow or blue latex (Ward’s Natural Science) into the apex of 
the left or right ventricle, respectively. Prior to overnight fixation in 10% neutral buffered 
formalin (Fisher Scientific) and storage in 70% ethanol, tissue samples from every 
embryo were obtained and stored at -20 Celsius for genomic DNA isolation. 
 
3.4.2 Genotyping of E17.5 embryos 
Genomic DNA was obtained from E17.5 embryos by phenol-chloroform 
purification (Sambrock and Russell, 2001).  Determination of LDS genotype and sex was 
done by PCR.  Briefly, amplification of the genomic region harboring the knock-in 
mutations followed by digestion with NciI or AlwI demonstrates a diagnostic restriction 
fragment for the presence of the mutation in Tgfbr1 or Tgfbr2, respectively. Primer 
sequences can be found in Appendix 1. 
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Sex of the embryos was determined by multiplex PCR amplification of a genomic 
region for the Phex1 and Sry genes, which rendered one or two bands for females and 






3.5 Tables: Chapter 3 
3.5.1 Table 3-1. Frequency of OFT Defects in Tgfbr1M318R/+ or Tgfbr2G357W/+ mice in 
a mixed background 
C57BL/6J wild-type 















Normal OFT 25 (100%) 43 (100%) 70 (100%) 32 (33%) 
OFT defects 0 0 0 65 (67%) 
 
3.5.2 Table 3-2. Frequency of OFT defects in Tgfbr1M318R/+ in a second backcross 
ontoC57BL/6J 
C57BL/6J wild-type 










Normal OFT 105 (100%) 55 (49%) 





3.5.3 Table 3-3. Distribution of the incidence of OFT Defects in Tgfbr2G357W/+ mice 
by sex * 
C57BL/6J wild-type 









Sex Male Female 
Normal OFT 7 7 
OFT defects 16 7 
 
*Table 3-3 only considers sex determination on a subset of embryos due to 




3.6  Figures: Chapter 3 
3.6.1 Figure 3-1. Outflow Tract Anatomy of Tgfbr1M318R/+ or Tgfbr2G357W/+ mice in a 
mixed genetic background 
 
Figure 3-1. A) Bilateral intraventricular injection of latex in heart of a 
Tgfbr2
G357W/+
 E17.5 embryo with normal anatomy shows complete separation of the right 
and left sides of the circulation with distinct delineation of the aorta and the pulmonary 
artery arising from the left (yellow) and right (blue) ventricles, respectively. B) 
Tgfbr2
G357W/+
 E17.5 embryo with patent truncus arteriosus (PTA) accompanied by an 
interrupted aortic arch (IAA). Bilateral intraventricular injection of latex demonstrates the 
septal defect (intracardiac mixing of colors) associated with PTA/IAA. A patent ductus 




3.6.2 Figure 3-2. TGFβ signaling required in OFT septation is modulated 
differentially by mutations in different subunits of TGFβ receptor complex and 
their interaction with C57BL/6J 
Figure 3-2. Effect of the interaction between LDS-causing mutations in Tgfbr1 or 
Tgfbr2 with C57BL/6J in incidence of OFT defects. A) Interaction of a LDS-causing 
mutation in Tgfbr2 with a haploid set of C57BL/6J chromosomes leads to OFT defects 
(PTA/IAA) (dominance test for Tgfbr2
G357W/+
 mice). B) Interaction of a LDS-causing 
mutation in Tgfbr1 with a haploid set of C57BL/6J chromosomes does not lead to OFT 
defects (PTA/IAA) (dominance test for Tgfbr1
M318R/+
 mice). C) A second backcross of 
Tgfbr1
M318R/+
 mice onto C57BL/6J is required to observe OFT defects. PTA requires a 
reduction of TGF signaling below a critical threshold that is achieved with a LDS 
mutation in one allele of a TGF receptor gene (Tgfbr2) and a hypomorphic opposing 
(C57BL/6J) allele of the same gene (A) or a LDS mutation in one allele of a TGF 
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receptor gene (Tgfbr1) and two hypomorphic (C57BL/6J) alleles of the other TGF 
receptor gene (Tgfbr2) (C). 
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4. CHAPTER 4. MAPPING GENETIC MODIFIERS OF THE 
CARDIOVASCULAR PHENOTYPE IN LDS MICE 
4.1 Introduction 
Phenotypic variation among individuals with a similar genetic background (i.e 
within the same family) has always been of great interest for geneticists. Diseases in 
which phenotypic features present with incomplete penetrance or variable expressivity 
certainly are appealing to study modification, assuming interaction between the disease-
causing mutation and some other locus or loci in the genome. 
Genetic modification is difficult to study using classic human genetic approaches 
(i.e linkage or association studies looking for alleles that segregate with the specific 
phenotype of interest). Contributing factors include the outbred nature of most Homo 
sapiens populations, and the confounding influence of allelic heterogeneity and 
environmental modification, as previously discussed.  
As highlighted by Risch and Merikangas (1996), the same limitations apply to the 
identification of susceptibility loci (or genes) for complex human traits or diseases 
through classical linkage studies. These authors argue that linkage can only be used when 
the genes to be identified have a strong effect on the phenotype (i.e. causal gene or major 
modifiers of the phenotype) and approaches in which many candidate genes can be tested 
at the same time (i.e. genome-wide association studies) would be limited by the need for 
large (and often limiting) sample sizes (Risch and Merikangas, 1996). 
Given these limitations, analysis of inbred mouse strains offers the opportunity to 
explore the relationship between the penetrance of a given phenotype and the distribution 
of alleles of causal and modifying genes (Risch et al., 1993). Typically, in the pre-
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genome sequencing era, strains of mice that showed high or low risk for the presence of 
the phenotype of interest were identified, intercrossed and used to map the susceptibility 
locus or loci to certain genomic region(s) in linkage disequilibrium with regard to the 
phenotype of interest. However, given the crude nature of existing linkage maps, it was 
difficult or impossible to associate loci of modification with mechanisms of modification.  
We used a modification of this approach to map a C57BL/6J-specific modifier of 
the cardiovascular phenotypes in our mouse models of LDS. As discussed in Chapters 2 
and 3, we have documented that the C57BL/6J strain interacts with LDS mutations to a) 
ameliorate postnatal development of aortic root aneurysm and dissection and b) 
predispose to a developmental cardiovascular phenotype, i.e. PTA. 
We chose to use PTA as our trait of interest for the mapping of the critical 
C57BL/6J modifier(s) because it is: a) a discrete and tractable phenotype that facilitates 
statistical genetic analyses, b) was shown to be highly specific to the interaction between 
the C57BL/6J background and LDS mutations, and c) has been previously associated 






4.2.1 Genome-wide SNP genotyping of E17.5 embryos with PTA and with normal 
heart anatomy 
288 genomic DNA samples were successfully collected and genotyped for a total 
of 1,449 SNPs corresponding to the entire set of SNPs contained in the Illumina™ Mouse 
Medium Density Linkage Panel. The distribution of these samples can be seen in table 4-
1. A subset of 860 SNPs are polymorphic between C57BL/6J and 129S6/SvEvTac. The 
mean call rate for this subset was 0.9996 with a Standard Deviation of 0.0014. The 
genotyping data corresponding to the remaining 589 SNPs were not analyzed due to lack 
of variation between these two strains (n=540) or technical failure (n=49). 
An association analysis with PLINK genetic analysis software (Purcell et al., 
2007) included 117 unaffected (normal heart anatomy) and 59 affected (OFT defects) 
LDS embryos. Generated p-values indicate whether the distribution of genotypes for each 
SNP is skewed relative to the presence or absence of OFT defects. In Figure 4-2 we 
represent these in the form of a Manhattan plot, highlighting a strong signal of 
association located in the distal region of mouse chromosome 9 (-log10(p)≈9) and a 
suggestive signal on mouse chromosome X (-log10(p)≈2.75). 
A list of the 20 highest ranked SNPs in this analysis is shown in Table 4-2. 
 
4.2.2  Gender-specific effect in the incidence of OFT defects in LDS embryos 
Upon the finding of a suggestive association signal in chromosome X we decided 
to assess whether the incidence of OFT defects correlated with gender. We observed that 
while 21/174 (12%) of female LDS embryos presented OFT defects, 43/171 (25%) of 
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males were affected with OFT defects (p=0.002, Fisher’s exact test). This difference in 
the incidence of OFT defects according to sex suggests that the signal observed in the 






In this chapter we have described the use of two inbred strains, namely C57BL/6J 
and 129S6/SvEvTac, and their interaction with LDS mutations, to map susceptibility loci 
for OFT defects. 
As discussed in chapters 3 and 4, this phenotype has been consistently associated 
with impairment of TGFβ signaling, is highly specific to C57BL/6J and displays a highly 
dominant effect in its interaction with the Tgfbr2
G357W 
allele. In addition, the dichotomous 
nature of OFTs (PTA or IAA) greatly simplified our association analysis in terms of costs 
and resources, as compared to the sample size and genotyping resolution that the 
mapping of a continuous trait (e.g. aneurysm growth rate) would require (Peters et al., 
2007). 
In our association analysis we observed a signal peak in the distal region of 
chromosome 9, a region that includes more than 400 genes in a span of approximately 40 
Mb. However, Tgfbr2 was the most prominent candidate gene in the region by virtue of 
its known function. Based on the genotyping data generated in this cohort of E17.5 LDS 
embryos, we estimate that in the genomic interval that harbors the SNPs with the highest 
–log(p) scores (chromosome 9), approximately 70% of those embryos with OFT defects 
carry a C57BL/6J-specific contribution, a result that leads to the conclusion that there 
may be more than one locus involved. 
This notion is reinforced by the finding of a secondary, suggestive signal on 
mouse chromosome X. Even though this signal does not reach genome-wide significance, 
it is significantly above the “noise” level and is certainly higher than the uncorrected –
log(0.05) value corresponding to the “suggestive” cut off value. As we will further 
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discuss in chapters 5 and 6, this region also harbors candidate genes that are intimately 
related to the regulation of TGFβ signaling and that have not previously been studied in 





4.4 Materials and methods 
4.4.1 Animal Models 
Animals were housed and experiments were performed with approval by the 
Johns Hopkins School of Medicine Animal Care and Use Committee. Tgfbr2
G357W/+
 LDS 
mice were previously generated and described in our lab (Gallo et al., 2014).  Six- to 
twelve-week old wild-type C57BL/6J (Strain# 000664, The Jackson Laboratory (Jax), 
Bar Harbor, ME) or 129S6/SvEvTac female mice (Taconic Laboratories) were crossed to 
six- to twelve week old wild-type males from a 129S6/SvEvTac background. The 
resulting litters (C57BL/6J/129S6/SvEvTac F1, or “F1”) were bred again in a brother-
sister pattern to generate F2 mice with extensive recombination between C57BL/6J and 
129S6/SvEvTac chromosomes. 
Females from this F2 generation were then mated to Tgfbr2
G357W/+
 LDS males 
congenic on 129SvE in order to generate E17.5 embryos that were phenotyped for the 
presence of PTA or IAA. Furthermore, some F2 females were mated to pure 
129S6/SvEvTac males and the females generated in this cross were bred again to 
Tgfbr2
G357W/+
 129SvE LDS males to obtain E17.5 embryos with a lower contribution of 
the C57BL/6J genome (up to 12.5%). 
Litters were genotyped for the presence of the respective LDS mutations as 
described elsewhere (Gallo et al., 2014). For a graphical depiction of the breeding 
strategy performed refer to figure 4-1. 
Following halothane-induced euthanasia of pregnant females, E17.5 embryos 
were harvested and their cardiovascular anatomy was observed upon dissection of the 
abdominal and thoracic walls and injection with approximately 0.5 ml of yellow or blue 
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latex (Ward’s Natural Science) into the apex of the left or right ventricle, respectively. 
Prior to overnight fixation in 10% neutral buffered formalin (Fisher Scientific) and 
storage in 70% ethanol, tissue samples from every embryo were stored at -20 celsius for 
further genomic DNA isolation. 
 
4.4.2 Genome-wide SNP genotyping 
Genomic DNA obtained from LDS E17.5 embryos (58 with PTA and 117 with 
normal OFT anatomy) was submitted for genome-wide SNP genotyping at the Center for 
Inherited Diseases Research (CIDR, Baltimore, MD) via the Genetic Resources Core 
Facility at The Johns Hopkins University School of Medicine. Briefly, 100 ul of genomic 
DNA at a concentration of 125 ng/ul was probed on the Illumina™ Mouse Medium 
Density Linkage Panel, which consists of 1,449 loci (SNPs) optimized for mapping and 
characterization of intercrosses between different strains of mice. 
The Illumina™ GenomeStudio software version 2011.1, Genotyping Module 
version 1.9.4 (Illumina Inc, San Diego CA) was used as the SNP genotype-calling 
algorithm. A complete list of the set of markers used in this experiment can be found at 
http://support.illumina.com/array/array_kits/mouse_md_linkage/downloads.ilmn. 
Genotyping data from these samples was used to perform an association analysis 
as calculated with the PLINK genetic analysis software (Purcell et al., 2007). Briefly, 
PLINK requires a file with genotyping data for each SNP included in the study as well as 
phenotypic (with PTA, without PTA) and covariate information (sex), which is 
comprised in a file with extension “.ped”; information about the SNPs studied, including 
chromosome #, rs# and position in bp are incorporated in a file with extension “.map”. 
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PLINK was run on these files using the options >Plink --file [filename] – map3. Results 
from this analysis are found in a file with extension “.assoc” which contains data 
required to generate a “Manhattan plot” using an open code published by Dr. Stephen 






4.5 Tables: Chapter 4 
4.5.1 Table 4-1. Samples submitted for Genome-wide SNP genotyping 
Category # 
Experimental 258 
Blind duplicates 12 
Internal Controls (CIDR) 12 






4.5.2 Table 4-2. SNPs with highest scores of association with OFT defects in a mouse 
model of Loeys-Dietz Syndrome 







9 rs3669563 117915299 0.3509 0.08621 9.84E-10 5.73 
9 rs6320810 115127089 0.3509 0.09483 5.31E-09 5.16 
9 rs13480421 111899990 0.3246 0.1034 3.92E-07 4.165 
9 rs3669564 88247268 0.4298 0.2155 3.39E-05 2.744 
9 rs3711089 105473772 0.2895 0.1164 6.41E-05 3.093 
9 rs13480399 106278521 0.2895 0.1164 6.41E-05 3.093 
9 rs3717654 101934506 0.2719 0.1164 0.000272 2.836 
9 CEL-
9_95875215 
95929537 0.2807 0.125 0.000354 2.732 
9 rs3689336 96311466 0.2807 0.125 0.000354 2.732 
9 rs3700596 86645978 0.2719 0.125 0.000691 2.614 
9 gnf09.087.298 90572378 0.2719 0.125 0.000691 2.614 
9 rs13480351 94192229 0.2719 0.1293 0.001068 2.515 
X gnfX.044.260 55491587 0.5467 0.337 0.001819 2.372 
X rs13483765 52289226 0.5467 0.3425 0.002435 2.315 
X petM-05810-1 64331236 0.5333 0.3315 0.00259 2.305 
X CEL-
X_60181392 
63283641 0.5333 0.337 0.003445 2.248 
X rs3157124 66109532 0.5333 0.3425 0.004542 2.194 
X rs13483831 70389009 0.5333 0.3481 0.005938 2.141 
X rs3725966 80159223 0.52 0.3536 0.01347 1.98 
X CEL-
X_154048891 





4.6 Figures: Chapter 4 
4.6.1 Figure 4-1. Breeding structure design for mapping modifiers of the 
cardiovascular phenotype in a mouse model of LDS 
 
Figure 4-1. Representation of the pedigree structure used to generate a cohort of 
LDS E17.5 embryos with extensive recombination between C57BL/6J and 
129S6/SvEvTac chromosomes. Two groups of Tgfbr2
G357W/+
 embryos were used for our 




4.6.2 Figure 4-2. Genome-Wide Association analysis of OFT defects in a mouse 
model of LDS 
 
Figure 4-2. Representation of Genome-Wide Association for of OFT defects in 
Tgfbr2
G357W/+
 E17.5 mouse embryos. The –log10(p) of the calculated p-value for each of 
the 860 SNPs included in this analysis is plotted as a function of the genomic location of 
the SNP. Blue line represents –log10(0.05) or the unadjusted p-value cut-off for 
significance; red line represents –log10(0.05/860) or the Bonferroni-adjusted p-value cut-






5. CHAPTER 5. INTERACTION BETWEEN CANDIDATE GENES IN THE 
REGIONS OF ASSOCIATION 
5.1 Introduction 
Classification of traits or diseases according to their mode of inheritance as 
monogenic, polygenic or complex (the latter implying a strong influence of the 
environment) was a proper approach during the early efforts for identification of 
susceptibility locus/loci. When genome-wide screening became available, whether by 
linkage or association, the observation of multiple signals raised the question of whether 
these findings implied independent causes of disease (locus heterogeneity) or an 
interaction between genes at different loci (epistasis) (Vieland and Huang, 2003). While 
linkage studies generate regions of interest that are never smaller than 2-5 Mb, GWAS 
hits are located in linkage disequilibrium (LD) blocks that are comparatively shorter (< 
100 kb) (Ott et al., 2011). However, in both cases, dozens if not hundreds of genes can be 
found in regions of interest, and without a well-founded list of candidate genes (that is, 
with strong biological basis for implication in the disease/trait of interest) the likelihood 
of identifying gene-gene interactions is very low, particularly in the case of quantitative 
traits. 
In the case of qualitative traits, and especially those of dichotomous nature, 
estimations of penetrance of the trait are used to calculate the effect of each of the loci 
tested. However, not every statistical model drawn from genotyping data can be matched 
with a true genetic or biological interpretation, which leaves unanswered the question of 
whether two loci are truly interacting with one another in the generation of the trait of 
interest (Sepulveda et al., 2007). 
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The fact that complex binary traits usually display incomplete penetrance has 
generally been interpreted as evidence that gene-gene and gene-environment interactions 
can modify the action of the phenotype-conferring alleles. However, this hypothesis falls 
short when “pure” genomes and a controlled environment (i.e inbred mice in any modern 
animal facility) display incomplete penetrance for the development of any given 
qualitative trait. These observations have prompted the hypothesis of an intrinsic 
stochastic property in the expression of a genotype at the level of the phenotype 
(Sepulveda et al., 2007). This can be particularly important in perturbations of 
morphogenesis, where chance fate decisions in a few progenitor cells can have a 
profound impact on phenotype. 
In this scenario, epistasis would have mainly two components: the intrinsic 
probability of the phenotype-causing allele being expressed and the interaction (if any) of 
this allele(s) with other alleles or the environment. Several operational definition of 
epistasis have been proposed: functional epistasis relates to the molecular interactions 
that proteins (and other genetically-determined elements) have with one another; 
compositional epistasis, describes epistasis as the blocking effect of one allele by an 
allele at another locus (i.e protective or detrimental effect of a second allele); statistical 
epistasis relates to the situation in which “the average deviation of combinations of 
alleles at different loci is estimated over all other genotypes present within a population” 
(Phillips, 2008). 
In light of these definitions, we aimed at elucidating whether the two loci detected 
by GWAS in our mouse models of LDS in a mixed background between C57BL/6J and 
129S6/SvEvTac displayed epistatic interaction, focusing primarily on statistical epistasis 
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as a way of understanding whether the C57BL/6J contribution to the background of LDS 
mice with PTA was enriched beyond what could be expected by chance when compared 
to those LDS mice with a normal heart anatomy. 
In this chapter, we show that there is an increased frequency of PTA in those mice 
harboring C57BL/6J alleles at both loci, that this effect is highly significant, and that 
while the locus on chromosome 9 is the major modifier, the locus on chromosome X had 







5.2.1 Penetrance of PTA is increased in the presence of C57BL/6J alleles at both 
chromosome 9 and chromosome X loci in mice with a Tgfbr2
G357W
 allele 
If epistatic interaction between the loci on chromosome 9 and X exists, then the 
penetrance of PTA is expected to be unevenly distributed across the different 
combinations of C57BL/6J alleles at these loci. That is, the presence of C57BL/6J alleles 
at both loci should increase penetrance of PTA beyond that expected for each locus by 
itself. Genotyping data used for GWAS analysis (Chapter 4) was analyzed stratified by 
phenotype and locus. We find that penetrance of PTA in mice with C57BL/6J alleles at 
both loci is much higher than expected from our previous observations (test of 
dominance) and thereafter follows a distribution that documents strong interaction 
between these two loci. 
Indeed, the pairwise comparisons for the penetrance of PTA in the different 
genotypic classes are significant for almost every pair of categories. Moreover, a general 
trend test, that seeks to compare the observed results to the null hypothesis that every 
category has the same probability of showing the phenotype (which is interpreted as lack 
of interaction between loci) is highly significant (p<1E-7), confirming our predictions 
(Figure 5-1). 
We conclude that when the LDS-causing mutation is in the Tgfbr2 gene and the 
opposite Tgfbr2 allele derives from the C57BL/6J background, 47% of mice show PTA. 
However, this frequency goes up to 87% if this configuration is accompanied by 
homozygosity (females) or hemizygosity (males) for C57BL/6J alleles at the 
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chromosome X locus. Indeed, for all genotypic combinations, the penetrance of PTA 
titrates the combined contribution of the C57BL/6J background at both loci (Figure 5-1). 
These observations support the hypothesis that the incidence of PTA is largely 
dependent on the C57BL/6J contribution on chromosome 9 (Tgfbr2 locus), but is 
thereafter strongly modified by the extent of C57BL/6J contribution at chromosome X. 
 
5.2.2 Penetrance of PTA is exacerbated in the presence of C57BL/6J alleles at both 
chromosome 9 and chromosome X loci in mice with a Tgfbr1
M318R
 allele 
On the basis of the results described above for the Tgfbr2
G357W
 allele, we reasoned 
that a similar epistatic interaction between the loci on chromosome 9 and chromosome X 
should also manifest itself in the case of Tgfbr1
M318R/+
 mice after a second backcross onto 
C57BL/6J which, on average, display a frequency of PTA of approximately 50% 
(Chapter 3, table 3-2). In fact, we observed that penetrance of PTA is increased among 
Tgfbr1
M318R/+
 mice carrying C57BL/6J alleles at both the Tgfbr2 locus (chromosome 9) 
and the locus on chromosome X, with a decreasing penetrance of PTA observed in 
proportion to the presence of 129S6/SvEvTac alleles at the loci of interest (Figure 5-2). 
Following the same principle as in the analysis for mice carrying the Tgfbr2
G357W
 
allele, mice with the LDS-causing mutation in Tgfbr1 (which is located in mouse 
chromosome 4) show PTA at a frequency varying from 61% for those carrying two 
C57BL/6J alleles at the Tgfbr2 locus and only C57BL/6J alleles at chromosome X to 






Our efforts to map regions of the C57BL/6J genome that were associated with 
PTA in the context of an LDS-causing mutation predicted that one locus on chromosome 
9, in the region that contains the Tgfbr2 gene, was significantly associated with our 
phenotype of interest. It also confirmed that other regions in the genome (chromosome X) 
displayed a moderate association that was, however, beyond the noise level and deserved 
further attention. 
As discussed previously, linkage or association studies can yield more than one 
genomic region as significantly correlated with a phenotype of interest; reasons include 
locus heterogeneity (in which two or more loci can cause the phenotype independently of 
each other) or genetic epistasis (in which two or more loci interact in producing the 
phenotype). 
We have demonstrated that in a population with random distribution of C57BL/6J 
and 129S6/SvEvTac alleles (such as the one used for our GWAS study), there is a 
significant epistatic interaction between the locus on chromosome 9 and the locus on 
chromosome X in mice carrying the Tgfbr2
G357W
 allele. The same trend was also 
observed in mice carrying the Tgfbr1
M318R 
mutation, with the caveat that these mice 
derive from a second backcross from 129S6/SvEvTac onto C57BL/6J and as such, are 
75% C57BL/6J, on average.  
The data presented in this chapter reveal that the interaction of these two regions 
is a bona fide example of statistical epistasis. However, it raises important questions in 
regard to the functional aspects of this relationship and more specifically, how do these 
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two loci interact to modulate TGFβ signaling to such an extent that the penetrance of 





5.4 Materials and methods 
5.4.1 Analysis of interaction between loci on chromosome 9 and X in Tgfbr2G357W/+ 
mice 
Genotyping data generated for the GWAS previously performed (Chapter 4) was 
used to designate the genotypes in the SNPs that marked the regions of association for 
both loci. Genotypes at rs3669563 were used to discriminate between C57BL/6J and 
129S6/SvEvTac alleles at the chromosome 9 locus, while genotypes at gnfX.044.260 
were used for allelic discrimination at the chromosome X locus. 
 
5.4.2 Analysis of interaction between loci on chromosome 9 and X in Tgfbr1M318R/+ 
mice 
SNPs at the chromosome 9 locus (rs13480439) and the chromosome X locus 
(rs13483770) were genotyped by Taqman™ SNP genotyping (Life Technologies) in a 
7900HT platform (Applied Biosystems) using the Allele Discrimination standard 
protocol. Every genotype call was made with >95% Quality Score over two technical 
replicates. 
 
5.4.3 Statistical analysis 
Statistical analyses were done with the package R (http://www.R-project.org). In 
pairwise comparisons, p-values refer to Fisher’s exact test for a 2x2 contingency table. 
The trend test was performed using the prop.trend.test command which compares the 
observed frequencies to the expected ones according to scores previously assigned to 





5.5.1 Figure -5-1. Segregation analysis of C57BL/6J alleles in E17.5 
Tgfbr2
G357W/+
mice with extensive recombination between C57BL/6J and 
129S6/SvEvTac reveals epistasis between chromosome 9 and chromosome X 
loci 
 
Figure 5-1. Incidence of PTA is primarily determined by the presence of a 
C57BL/6J allele (opposite to the one carrying the LDS mutation) at the chromosome 9 
locus, but is thereafter further modified by C57BL/6J alleles at chromosome X. 
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5.5.2 Figure 5-2. Segregation analysis of C57BL/6J alleles in E17.5 
Tgfbr1
M318R/+
mice from a second backcross onto C57BL/6J (from 
129S6/SvEvTac) reveals epistasis between loci on chromosome 9 and 
chromosome X 
 
Figure 5-2. Penetrance of PTA in Tgfbr1
M318R/+
mice is also dependent of the 
interaction between chromosome 9 and chromosome X loci. The presence of C57BL/6J 
alleles at chromosome 9 is the major driver for occurrence of PTA but is thereafter 




6. CHAPTER 6. STRAIN-SPECIFIC VARIANTS IN THE TGFBR2 3’UTR 
INFLUENCE GENE EXPRESSION 
6.1 Introduction 
Post-transcriptional regulation of gene expression requires coordination of 
complex machinery within the cell. It includes addition of the 5’ monomethylated CAP 
structure and subsequent binding of the cap binding complex (CBC) as well as protection 
of the 3’ end of the transcript through binding of the Poly-A binding protein (PABP) 
complex. 
The role of untranslated regions of a transcript (UTRs) has been under intense 
scrutiny in the last decades, and it is now well understood that variants in these regions 
can have major effects on gene expression by affecting translation efficiency or mRNA 
stability, or both. The 5’UTR provides a substrate for the translation initiation complex to 
bind and scan for the first AUG codon and changes in its sequence can affect this series 
of events either by disruption of a binding sequence or by formation or modification of 
secondary structures required for these purposes. An example of how variants in the 
5’UTR can affect gene expression and lead to disease states is found in the BRCA1 gene, 
which normally works as a tumor suppressor gene. However, a G to C substitution in 
position -3 in regard to the initiation AUG, which was first described as a somatic 
mutation found in breast cancer patients, was shown to significantly down-regulate 
protein translation (Signori et al., 2001). 
3’UTR sequences also play a key role in mRNA stability and translation 
efficiency. It has been reported that mutations that affect termination codons, and 
therefore the length of the 3’UTR may create unstable transcripts. The polyadenylation 
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signal (AAUAAA) is another element that, if mutated, can lead to changes in translation 
efficiency which may result in a phenotype, as in the case of mutations in the 
polyadenylation signal of the FOXP3 gene in the context of a syndrome called IPEX (for 
Immune dysfunction, Poly-endocrinopathy and Enteropathy, X-linked). 
Mutations that alter the structure of the 3’UTR can also cause diseases through 
disruption of interactions with factors that influence mRNA stability, trafficking and 
translation (Mendell and Dietz, 2001).  
Another prominent mechanism of regulation of gene expression related to the 
3’UTR involves microRNAs (miRNAs or miRs). These 20-24 bp RNA sequences bind 
through base-pairing complementarity to sites in the 3’UTR of target genes and repress 
gene expression through induction of mRNA degradation or (more commonly) inhibition 
of translation. Mutations in miRNA binding sites have been shown to generate dramatic 
increases in gene expression with phenotypic consequences, including activation of 
proto-oncogenes in some cancers (Mayr and Bartel, 2009). 
As described in chapter 4, we have identified two major loci associated with PTA 
in LDS mice, one major locus on chromosome 9 coincident with the genomic location of 
Tgfbr2, and one minor locus on chromosome X. This minor signal centers on the gene 
encoding the miR-106a~363 locus. Interestingly, this locus contains two microRNAs, 
miR-20b and miR-106a that are predicted to target the 3’UTR of Tgfbr2. 
We hypothesized that molecular interaction between these two miRNAs and the 
3’UTR of Tgfbr2 is at the basis of the epistatic interaction previously demonstrated from 
a statistical standpoint in chapter 5. 
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In this chapter, we show that the 3’UTR from the C57BL/6J allele of Tgfbr2 
differs in five positions with respect to the 129S6/SvEvTac allele, and that these 
differences have functional consequences on the translation efficiency of Tgfbr2 
consistent with our hypothesis that the C57BL/6J background associates with a lower 
TGFβ signaling environment. Moreover, we show that these differences in translation 







6.2.1 Aortic tissue from C57BL/6Jmice express higher levels of primary transcript 
and mature microRNAs that target Tgfbr2 
Given the potential critical role played by the two microRNAs encoded at the 
chromosome X locus of interest in regulation of the translation efficiency of the Tgfbr2 
transcript, we measured their levels in the two strains of interest by quantitative RT-PCR 
on RNA extracted from aortic tissue. 
Our results indicate that tissue from C57BL/6J has significantly higher levels of 
the primary transcript encoding both miR-20b and miR-106a. This trend was also 
observed when the mature microRNAs were quantitated. In this case, the difference was 
statistically significant in the case of mmu-miR-20b but not in the case of mmu-miR-106a, 
although C57BL/6J also showed slightly higher levels of this transcript (Figure 6-4). 
However, we did not observe significant differences in the levels of Tgfbr2 
transcript between the two strains (Figure 6-4), suggesting that levels of receptor 
expression might only be influenced at the level of translation efficiency and not mRNA 
stability. 
 
6.2.2 VSMCs derived from C57BL/6J display lower levels of TRII expression and 
TGFβ signaling as compared to 129S6/SvEvTac 
On the basis of our results indicating that expression levels of the miRNAs that 
inhibit the translational efficiency of Tgfbr2 are higher in the C57BL/6J, we wanted to 




Using flow cytometry we were able to simultaneously quantify both receptor 
expression and levels of SMAD2 phosphorylation (pSMAD2) in primary cultures of 
vascular smooth muscle cells derived from the ascending aorta of mice of either strain. 
This analysis was conducted both in the absence and presence of TGFβ1, at different time 
points. 
Our results indicate that VSMCs derived from C57BL/6J aortas display lower 
levels of TβRII on their surface than their 129S6/SvEvTac counterpart. While there 
appears to be a slight difference when cells are grown at steady-state in serum, this 
difference becomes statistically significant at and beyond 15 min of incubation with 1 
ng/uL of TGFβ1 (p<0.01) (Figure 6-5). TGF stimulation leads to acute internalization of 
receptor complexes at the cell surface, with repopulation of surface expression being 
largely dependent on de novo protein synthesis.  The difference in receptor levels 
associates with lower levels of pSMAD2 in C57BL/6J VSMCs as compared to 
129S6/SvEvTac VSMCs, which is most evident after 30 minutes of stimulation with 
TGFβ1 (Figure 6-5). 
 
6.2.3 Identification of strain-specific variants in the 3’UTR of Tgfbr2 
Whole-genome next-generation sequencing data have been made publicly 
available by the Mouse Genome Project at the Wellcome Trust Sanger Institute and a 
Data Query web-interface (http://www.sanger.ac.uk/sanger/Mouse_SnpViewer/rel-1303) 
allows users to access Single Nucleotide Polymoprhisms as well as small insertions and 
deletions and structural variants across 17 strains of mice, including three substrains of 
129S and C57BL/6N. A total of 8 variants were found to be polymorphic between 
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C57BL6N and 129S in the Tgfbr2 gene according to this source. The distribution of these 
variants throughout the Tgfbr2 gene is annotated in Table 6-1 and shown in Figure 6-1. 
Five variants, which are localized in the 3’UTR region of Tgfbr2, were confirmed by 
Sanger sequencing of genomic DNA from wild-type C57BL/6J and 129S6/SvEvTac 
animals. The two strain-distinguishing SNPs in the coding region of Tgfbr2 are 
synonymous, and are therefore unlikely to contribute to functional differences between 
the strains. 
 
6.2.4 Transcripts carrying Tgfbr2 3’UTR derived from C57BL/6J show reduced 
translational efficiency as compared to 129S6/SvEvTac 
To address the potential effect of the polymorphic variants that distinguish 
C57BL/6J from 129S6/SvEvTac we introduced the entire 3’UTR from each strain into a 
reporter vector that encodes firefly luciferase. We then assayed the reporter constructs in 
NIH/3T3 cells in order to eliminate any potential confounding effect caused by assessing 
the reporter in cell lines derived from either of the strains being interrogated. We 
observed that the reporter allele containing the C57BL/6J 3’UTR had approximately 50% 
less normalized luciferase activity, when compared to the one with the 129S6/SvEvTac 
3’UTR (p<5E-8) (Figure 6-2). 
 
6.2.5 Tgfbr2 3’UTR from both strains are highly sensitive to alterations on the 
intracellular levels of mmu-miR-20b and -106a 
Upon characterization of strain-specific differences in translation efficiency of a 
transcript that includes the 3’UTR of Tgfbr2 from each strain, we decided to investigate 
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the hypothesis that miRNAs encoded at the mmu-miR-106~363 locus in mouse 
chromosome X, which are predicted to target this 3’UTR, can have a significant impact 
on translational efficiency of our reporter alleles. 
We transfected NIH/3T3 cells with mirVana™ inhibitors of mmu-miR-20b or 
mmu-miR-106a, hypothesizing that inhibiting these miRNAs would increase translation 
efficiency from either reporter vector. Indeed, we observed increased activity for reporter 
alleles harboring either the C57BL/6J or 129S6/SvEvTac 3’UTR upon administration of 
either anti-miR. Of particular note was the full equalization of activity between the 






In Chapter 5 we described a potent interaction between the two loci of interest 
discovered through our GWAS study and subsequent segregation analysis of C57BL/6J 
alleles and PTA. Through the series of experiments described in this chapter, we have 
shown that polymorphic variants in the 3’UTR of Tgfbr2 that distinguish the two strains 
of mice have a significant effect on the translational efficiency of this transcript, which 
can be as much as 50% in our reporter system, with C57BL/6J displaying lower 
expression. 
This difference is abolished when intracellular levels of the microRNAs located at 
the chromosome X locus are altered, implying that translation levels of Tgfbr2 are 
directly modified by mmu-miR-20b and -106a. 
We have also showed that aortic tissue extracted from C57BL/6J mice displays 
higher expression levels of both primary transcripts and mature miR-20b and miR-106a. 
This difference strongly supports our hypothesis that C57BL/6J offers a low TGFβ 
signaling environment, as previously documented, and that the source of this 
modification lies in a post-transcriptional modification. 
In keeping with our hypothesis, when VSMCs derived from aortic tissue of either 
strain of mice were stimulated with TGFβ1 ligand we observed that both cell surface 
levels of TβRII and intracellular levels of pSMAD2 were consistently lower in cells 
derived from C57BL/6J mice, in agreement with the observation that PTA, a condition 
triggered by impaired TGFβ signaling, is more penetrant in mice that carry a LDS-
causing mutation in the context of increased C57BL/6J contribution at the loci of interest. 
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We are currently trying to understand the source of this functional variation in the 
context of the variants localized in the 3’UTR of Tgfbr2. Other authors have suggested 
the relevance of folding structure of mRNAs for the efficiency of its targeting by 
miRNAs (Long et al., 2007). Our in silico mRNA folding studies suggest that the 
C57BL/6J 3’UTR has a more open conformation in the region of the miR-106a/20b 
binding site, when compared to the 129SvE 3’UTR, perhaps allowing greater 
accessibility (Figure 6-6). This would explain how variation in the 3’UTR that is distant 
from the binding site could influence miR performance. 
We have summarized these findings and a model to explain strain-specific 
phenotypic variation both during embryonic development and postnatal aneurysm 






6.4 Materials and methods 
6.4.1 Cell culture 
3T3 immortalized mouse fibroblasts were grown in DMEM supplemented with 
10% fetal bovine serum (FBS), Antibiotic-Antimycotic and L-glutamine, at 37°C and a 
5%CO2 atmosphere. 
Primary aortic VSMC cultures were established from the roots and proximal 
ascending aortas of 10-week-old mice from each strain. Aortas were digested in 300U/ml 
collagenase II (Worthington Biochemical Corp.) in HBSS (Life Technologies) with 
Antibiotic-Antimycotic for 20 minutes at 37°and the endothelium and adventitia were 
removed. Following an overnight incubation in DMEM (Life Technologies) with 20% 
FBS, aortas were washed with HBSS and digested with 300 U/ml collagenase II and 
3U/ml elastase for 45 minutes at 37°C. Aortas were minced into small pieces and 
incubated with DMEM plus 20% FBS. Seven to ten days were allowed for VSMCs to 
adhere to the plate, after which the media was changed to DMEM plus 10% FBS. 
 
6.4.2 Molecular Cloning 
The 3’UTR region of the Tgfbr2 gene from C57BL/6J and 129SvE was PCR 
amplified from mouse genomic DNA (Thermo Scientific, Pittsburgh, PA #F548). Primers 
used are in Appendix 2. PCR fragments were cloned into an XbaI restriction site in the 
pGL3-Control Vector (Promega, Madison, WI # E1741) with the In-Fusion®HD Cloning 
Plus kit (Clontech Laboratories Inc, Mountain View, CA, #638909). Vector sequences 




6.4.3 Dual Luciferase Assays 
2.5 × 10
5
 NIH/3T3 cells were plated in 24-well plates and transfected 24 hours 
later with 200 ng of 3’UTR vector (Empty, 3;UTR-C57BL/6J or 3’UTR-129SvE), 5ng of 
phRL-SV40 (Promega, Madison, WI) and 50 nM of anti-mmu-miR-20b-5p or anti-mmu-
miR-106a-5p or Anti-miR negative control mirVana™ miRNA inhibitor (Ambion® / 
Life Technologies, Grand Island, NY, #MH10975, #MH12726) using Turbofect (Thermo 
Scientific, Pittsburgh, PA, #R0531) according to the manufacturer’s protocol.  For each 
condition, six biological replicates were performed. 24 hours after transfection, cells were 
lysed and assayed for firefly and renilla luciferase activity using the Dual-Luciferase 
Reporter Assay System (Promega, Madison, WI, #E1960).  Firefly luciferase activity was 
normalized to Renilla luciferase activity for each transfected well. 
 
6.4.4 Flow Cytometry 
VSMCs were grown to approximately 70% confluence in DMEM plus 10% FBS.  
Cultures were starved in 2% serum for 24 hours before analysis.  Cells were lifted from 
cultures plates by adding ice-cold 0.5 mM EDTA for 10 minutes, washed twice with 
PBS, and then resuspended in PBS containing 0.5% BSA (Flow Cytometry Staining 
Buffer).  Cells were stained with APC-conjugated anti-mouse TβRII antibody (R&D 
Systems, FAB532A) or APC-conjugated isotype control antibody (R&D Systems, 
IC108A) by adding 10 µl of antibody to 10
6
 cells in 100 µl.  Cells were incubated for 60 
minutes on ice in the dark.  Unbound antibody was removed by washing the cells in Flow 
Cytometry Staining Buffer twice. Stained cells were then fixed for 10 minutes at room 
temperature in 4% PFA in PBS, washed twice with Flow Cytometry Staining Buffer, and 
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resuspended in 1 ml Flow Cytometry Staining Buffer prior to acquisition. Flow 
cytometry data were acquired on a BD FACSVerse flow cytometer (BD Biosciences).  
Alternatively, an aliquot of these cells was permeabilized overnight in 90% 
methanol and stained for intracellular levels of phosphorylated SMAD2 by adding 5 µl of 
antibody (Cat. # 562586, BD Biosciences) to 10
6
 cells in 50 µl. Cells were incubated for 
60 minutes on ice in the dark. Unbound antibody was removed by washing the cells in 
Flow Cytometry Staining Buffer twice and resuspended in 1 ml Flow Cytometry Staining 
Buffer prior to acquisition. Flow cytometry data were acquired on a BD FACSVerse flow 
cytometer (BD Biosciences). 
Results were evaluated, including median fluorescent intensity (MFI) calculations 
using FlowJo software (Tree Star Inc.) 
 
6.4.5 RNA extraction and quantitative real-time PCR 
Aortic tissue was processed using the miRNeasy Mini Kit (Qiagen) plus an 
automatic bead homogenizer (FastPrep24, MP Biomedicals). For all the extractions, an 
on-column DNAse digest was performed using an RNAse-free DNAse kit (Qiagen). 
cDNA was prepared according to the manufacturer’s protocol with a TaqMan 
High-Capacity cDNA Reverse Transcription kit (Life Technologies). Alternatively, 
cDNA specific for quantification of mature microRNAs was prepared according to 
manufacturer’s protocol with a TaqMan™ MicroRNA reverse Transcription Kit and 
primers specific for mmu-miR-20b and -106a. 
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Quantitative PCR was performed in three technical replicates per sample with 
TaqMan™ Universal PCR Master Mix using an Applied Biosystems QuantStudio™ 7 
Flex Real-Time PCR System (Life Technologies) 
 
6.4.6 Statistical analysis 
Statistical analyses were done with the package R (http://www.R-project.org). 





 percentiles, respectively; internal line defines the median, and 
the whiskers define the range.  In pairwise comparisons, p-values refer to unpaired 2-
tailed Student’s t test. 
 
6.4.7 In silico mRNA folding 
Predicted folding structures for the stain-specific 3’UTRs were generated using 














116,175,080 rs33371690 A G 5’ UTR 
116,090,516 rs245019337 G A CDS, synonymous 
116,090,507 rs33371016 G A CDS, synonymous 
116,090,169 rs30321058 C T 3’ UTR 
116,090,000 rs29842530 T G 3’ UTR 
116,089,680 rs13468749 C G 3’ UTR 
116,089,123 rs33663743 C A 3’ UTR 






6.6.1 Figure 6-1. Reporter constructs carrying Tgfbr2 3’UTR from C57BL/6J or 
129S6/SvEvTac 
 
Figure 6-1. Diagram of the reporter vectors used to study regulatory differences 
between A) C57BL/6J and B) 129S6/SvEvTac.  
 
6.6.2 Figure 6-2 .Assessment of translational efficiency of Tgfbr2 3’UTR from 
C57BL/6J and 129S6/SvEvTac mice through Dual Luciferase assay 
Figure 6-2. NIH/3T3s transfected with a reporter vector carrying the Tgfbr2 
3’UTR from C57BL/6J display significantly lower luciferase activity than those 





6.6.3 Figure 6-3. Sensitivity of Tgfbr2 3’UTR derived from C57BL/6J and 
129S6/SvEvTac to alterations in the levels of mmu-miR-20b or mmu-miR-106a 
 
Figure 6-3. NIH/3T3 cells were transfected with reporter vectors carrying the 
Tgfbr2 3’UTR from each of the indicated strains. At baseline, C57BL/6J shows lower 
levels of reporter translation than 129S6/SvEvTac. Upon addition of inhibitors of either 
mmu-miR20b or -106a these levels are equalized between the two strains. P-values were 





6.6.4 Figure 6-4. Quantification of RNA levels of candidate genes in the two regions 






Figure 6-4. RT-PCR quantification of expression levels of candidate genes found 
in the regions of association in aortic tissue obtained from female mice of either 
strain (n=3, 3 technical replicates each). A) Quantification of Tgfbr2 mRNA 
levels B) Quantification of primary transcript from the mmu-miR-106~363 cluster. 





6.6.5 Figure 6-5. Levels of surface TβRII and intracellular  pSMAD2 in VSMCs 
derived from C57BL/6J and 129S6/SvEvTac 
 
p<0.005  p<0.05  
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Figure 6-5. Flow cytometric analysis of receptor levels and intracellular signaling 
of VSMCs derived from each indicated strain in the presence of TGFβ1 for the indicated 
time points. A) VSMCs from 129S6/SvEvTac display higher levels of TβRII on their 
surface as compared to C57BL/6J. This difference is significant at 15 and 60 minutes 
(p<0.005 and p<0.05, respectively). B) VSMCs from 129S6/SvEvTac display higher 





6.6.6 Figure 6-6. Strain-specific variants in Tgfbr2 influence 3’UTR folding 
Conserved seed sequence for binding of mmu-miR-20b and -106a 
 
Figure 6-6 Folding structure for Tgfbr2 full-length mRNA as predicted by 
SFOLD. A) Location of the seed sequence for miR-20b and -106a in the 3’UTR of 
C57BL/6J-specific Tgfbr2. B) Location of the seed sequence for miR-20b and -106a in 




6.6.7 Figure 6-7. Modification of cardiovascular phenotypes in LDS mice depends on 
levels of expression of Tgfbr2 regulatory microRNAs and on strain-specific 
variation in the Tgfbr2 3’UTR 
Figure 6-7. Tgfbr2 expression at the level of translation would be influenced by 
both expression level and accessibility of microRNAs such as miR-20b or -106a. A) On 
the C57BL/6J background, variation on chromosome 9 promotes accessibility to the 
3’UTR of Tgfbr2 and variation on chromosome X dictates high expression of the miR-
106 cluster, lowering expression of the TRII receptor and TGFβ signaling, inducing 
OFT defects during embryonic development but ameliorating postnatal progression of 
aneurysm progression. B) On the 129S6/SvEvTac background, variation on chromosome 
9 dictates a less accessible 3’UTR of Tgfbr2 and lower expression of microRNAs, 
75 
 
culminating in higher expression of the TRII receptor and TGFβ signaling that promotes 





7. CHAPTER 7. CONCLUDING REMARKS 
 
This work demonstrates that the TGF signaling pathway can be subject to 
complex genetic modification with overt phenotypic consequences. Here, we show that 
strain-specific differences in the TGF vasculopathies relates to variation at distinct loci 
encoded on mouse chromosome 9 (Tgfbr2 locus) and chromosome X (miR-106a~363 
locus). Moreover, we show robust epistasis between these loci in determining the 
penetrance of PTA. Given the pseudodominant modification when the LDS mutation is in 
Tgfbr2, but recessive modification when the mutation is in Tgfbr1, our data document a 
complex architecture for modification that integrates the influence of both the primary 
disease locus and multiple modifying loci with additive effects ultimately determining the 
status of TGF signaling and hence the predisposition for disease. The different 
phenotypic outcomes of the interaction between strain-specific alleles of the Tgfbr2 gene 
and LDS-causing mutations in regard to OFT septation suggests that TGFβ signaling 
needs to meet highly specific spatial and temporal thresholds during embryonic 
development (See Figure 3-2). 
Additional complexity is illustrated by our demonstration that variation that 
dictates low TGF signaling is predisposing in one disease context (the predisposition for 
congenital heart disease) but protective in another (postnatal aneurysm progression) in 
the setting of the same primary disease allele. We believe that this level of complexity 
may prove relevant to other TGF vasculopathies and TGF-related disease states (e.g. 
fibrosis, chronic renal disease and cancer). Indeed, the literature suggests that the 
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C57BL/6J background is protective in mouse models of each of these common human 
conditions (Kato et al., 2008; Terzi et al., 2000). 
This work is the first to show strong evidence that the conformation of target gene 
3’UTRs can have a robust influence on miRNA accessibility and performance. In this 
light, variants in the 3’UTR of disease candidate genes should be specifically scrutinized 
for this type of functional consequence even if they do not involve nucleotides that 
participate in direct base pairing with regulatory miRs. 
The strong association between many inherited aneurysm conditions and TGF 
signaling, the gender bias in some of these disorders, and the specific localization of 
miRs that regulate TGF signaling to the X chromosome (in both mice and humans) 
offers a number of intriguing mechanistic hypotheses. For example, bicuspid aortic valve 
with aneurysm is a common human phenotype that shows a strong male bias. It has been 
noted that the miR-106a~363 gene escapes meiotic X inactivation. If true for X 
inactivation in general, a testable hypothesis, this might suggest that females (when 
compared to males) normally have increased expression of miRs that suppress TGFBR2 
expression and, on that basis, lower TGF signaling and hence protection from vascular 
disease. This same scenario might relate to the increased predisposition for aneurysm 
seen in Turner syndrome (karyotype X0) females. 
Of greatest immediate significance, these data place us on firm ground in the 
belief that, despite paradoxical discrepancies between the predicted effect of mutations 
causing LDS and apparent tissue consequences, that high TGF signaling is a major 
determinant of postnatal aneurysm progression. In this light, therapeutic strategies aimed 
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9. Appendix 1. Genotyping Primers for LDS mice. 
LDS GenotypingPrimers Sequence 5’-3’ 
Tgfbr1-M318R-Fwd GTT AAG GTG GCG TCA TGT TGC 
Tgfbr1-M318R-Rev ACC ACT GTG TCG AAA GGG AAG 
Tgfbr2-G357W-Fwd CGT GGC TGT CAA GAT CTT CCC 
Tgfbr2-G357W-Rev TGT TGG CCA GGT CAT CCA CAG 
 
Mouse Sex Determination 
Primers 
Sequence 5’-3’ 
Mmu-PHEX1-Fwd AGA TGT TGT GGG AGC TAA TCT CAG 
Mmu-PHEX1-Rev TAA CAA GTT GTC AGG GAA GGC 
Mmu-SRY-Fwd TTG TCT AGA GAG CAT GGA GGG CCA TGT CAA 
Mmu-SRY-Rev CCA CTC CTC TGT GAC ACT TTA GCC CTC CGA 
 
10. Appendix 2. Cloning primers for 3’UTR of Tgfbr2 
Primer name Sequence 5’-3’ 
Mmu-Tgfbr2-3UTR-Fwd GCC GTG TAA TTC TAG CTT TTT CTG GGC AGG 
CTG 
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pathogenesis.  Gallo EM, Loch DC, Habashi JP, Calderon JF, Chen Y, Bedja D, van Erp 
C, Gerber EE, Parker SJ, Sauls K, Judge DP, Cooke SK, Lindsay ME, Rouf R, Myers L, 
Ap Rhys CM, Kent KC, Norris RA, Huso DL, Dietz HC. J Clin Invest. 2014 Jan 
2;124(1):448-60. 
GluA3-deficiency in Mice is Associated with Increased Social and Aggressive Behavior 
and Elevated Dopamine in Striatum. Adamczyk A, Mejias R, Takamiya K, Yocum J, 
Krasnova I, Calderón JF, Cadet JL, Huganir R, Pletnikov M, Wang T. Behavioural 
Brain Research  2012 Apr 1;229(1):265-72. 
VEGFA polymorphisms and cardiovascular anomalies in 22q11 microdeletion syndrome: 
a case-control and family-based study.  Calderón JF, Puga AR, Guzmán ML, Astete CP, 
Arriaza M, Aracena M, Aravena T, Sanz P, Repetto GM.  Biol Res. 2009;42(4):461-8. 
Clinical features of chromosome 22q11.2 microdeletion syndrome in 208 Chilean 
patients.  Repetto GM, Guzmán ML, Puga A, Calderón JF, Astete CP, Aracena M, 
Arriaza M, Aravena T, Sanz P.  Clin Genet. 2009 Nov;76(5):465-70. Epub 2009 Sep 8. 
Presentations 
Calderon, JF and Dietz, HC. Interaction between a TGFβ effector and its regulatory 
microRNA influences aortic phenotypes in mouse models of TGFβ vasculopathies. HHMI 
Science Meeting. Chevy Chase MD, March 2014. Poster. 
 
Calderon, JF and Dietz, HC. Epistasis between the genes encoding a TGFβ effector and 
its regulatory microRNA governs modification of cardiovascular phenotypes in TGFβ 





Calderon, JF and Dietz, HC. Robust epistasis between the genes encoding a TGFβ 
effector and its regulatory microRNA governs modification of cardiovascular phenotypes 
in TGFβ vasculopathies. 63
rd
 Annual Meeting of The American Society of Human 
Genetics, Boston MA, October 2013. Platform presentation. 
 
Calderon, JF and Dietz, HC. Identification of a major genetic modifier locus for TGFβ 
vasculopathies in mice. 2nd Thoracic Aortic Disease Summit, Chicago IL, August 2012. 
Platform presentation. 
 
Calderon, JF, Dietz, HC. Identification of a major genetic modifier in mouse models of 
TGFβ vasculopathies.  62nd Annual Meeting of The American Society of Human 
Genetics, San Francisco CA, 2012. Poster. 
 
Adamczyk A, Mejias-Estevez R, Calderón J, Takamiya K, Huganir R, Pletnikov M, 
Wang T.  Mice lacking glutamate receptor 3 associated with significantly increased 
aggressive behaviors.  60th Annual Meeting of The American Society of Human 
Genetics.  Washington DC, 2010. Poster. 
 
Repetto GM, Calderon JF, Guzman ML, Puga A, Astete CP, Aracena M, Arriaza M, 
Aravena T, Sanz P.  Is VEGF a modifier of the cardiovascular phenotype of the 22q11 
microdeletion síndrome? 58th Annual Meeting of The American Society of Human 
Genetics.  Philadelphia PA, 2008. Poster. 
 
Calderón JF, Guzmán ML, Puga AR, Astete C, Aracena M, Mellado C, Aravena T, 
Arriaza M, Sanz P, Repetto GM. “Evaluación de polimorfismos en los genes MTHFR y 
VEGF y su asociación con la presencia de cardiopatías conotruncales en pacientes con 
deleción del cromosoma 22”. XL Anual Meeting of Genetics Society of Chile. Tomé, 
Chile (2007). Poster. 
 
Repetto GM, Calderón JF, Guzmán ML, Puga A, Astete CP, Aracena C, Mellado C, 
Aravena T, Arriaza M, Sanz P. “Chromosome 22q11 deletion syndrome: is MTHFR a 
95 
 
modifier of the cardiovascular phenotype?  57th Annual Meeting of The American 
Society of Human Genetics.  San Diego, California. USA (2007). Poster. 
 
Calderón JF, Guzman ML, Puga AR, Astete CP, Aracena MI, Mellado C, Aravena T, 
Repetto GM. “Polymorphisms in Genes Affecting Vascular Development and Folate 
Metabolism might modify the Cardiovascular Phenotype in Patients with Deletion 22q11 
Syndrome”.  3rd Internacional Conference on Birth Defects & Disabilities in the 
Developing World. Río de Janeiro, Brasil (2007). Poster. 
 
Verbeke S, Calderón JF, Chirdo FG, Brunser O. “Expression pattern of 
transglutaminase 2 in human small intestine.  Ultrastructural study.  VII Latin American 
Congress of Immunology.  Córdoba, Argentina (2005). Poster. 
 
Additional Meetings attended 
 




 Annual Short Course on Medical and Experimental Mammalian Genetics. 
The Jackson Laboratory, Bar Harbor ME. 
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